ICR video toggle
Published: 12 January 2021
-
Views:
98
-
Likes:
7
-
Views:
98
-
Likes:
7
-
Up Next -
Part 1 | Session 2 Test video
Overview
The Advancements in Atrial Fibrillation Detection and Treatment symposium brings together leading experts in the field of cardiology and electrophysiology to discuss topics including:
- Atrial fibrillation (AF) detection tools and associated evidence: selecting the right device for each patient
- How the latest AF detection devices can impact clinical practice
- AF detection and treatment guidelines
- The risk-benefit threshold of AF ablation compared to antiarrhythmic drug therapy
- Who should be referred for an AF ablation
- AF progression and the associated clinical impact
- The benefits associated with early AF treatment and first-line ablation
Faculty: Prof. Thorsten Lewalter, Prof. Helmut Pürerfellner, and Prof. Carina Blomström-Lundqvist
This educational content is supported by Medtronic.
Learning objectives
- AF detection tools that are best suited for different patients and how they can impact clinical practice
- AF detection and treatment guidelines
- Who should be referred for an AF ablation and what outcomes they can expect?
- AF progression and the benefits of early treatment
Target Audience
- The presentation recordings primarily target cardiologists. General practitioners, allied health professionals, and electrophysiologists may also benefit from this content.
More from this programme
Part 1
El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento
Part 2
Die Zukunft des Hypertoniemanagements – Renale Denervierung bietet eine weitere Behandlungsoption
Part 3
The Future of Hypertension Management - Renal Denervation Provides Another Treatment Option
Part 4
The Science of Renal Denervation
| 1 session | |
| The Science of Renal Denervation | Watch now |
Part 5
The science of renal denervation - Part 1
Part 6
Can Renal Denervation Benefit Patients with Hypertension?
Part 7
Comments